Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
Datavault AI signed a non-binding LOI to acquire a 19.9% fully diluted equity stake in DataMEDS AI in exchange for expanding its existing technology license to include Datavault AI Health capabilities. Datavault AI retains ownership of its underlying IP, while DataMEDS assumes commercialization costs and Datavault AI expects to participate in potential royalty revenue — a capital-efficient licensing-plus-equity structure. The company would also gain the right to one DataMEDS board seat.
Key figures
- Board right
- right to designate one director to DataMEDS board post-closing
- Stake basis
- fully diluted
- Equity stake pct
- 19.9%
- Targeted closing
- Q4 2026
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.